 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | cabotamig (ARB202) / Arbele
New P1 trial, Metastases: Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients (clinicaltrials.gov) - Jun 8, 2022
P1, N=68, Recruiting, Sponsor: Arbele Pty Ltd